Biogen Idec Inc. · Cambridge, MA United States ·(NASDAQ (GS): BIIB)
Company Description
Phone: 617-679-2000
Fax: 617-679-2617
Rankings
- #318 in FT Global 500
- S&P 500
View Biogen Idec Inc. Locations On A US Map
This link will open in a new window
When it comes to developing new and better biotech drugs, Biogen Idec believes two heads are better than one. The biotech giant, formed from the merger of IDEC Pharmaceuticals and Biogen , is focused on developing treatments in the areas of oncology, immunology, and neurology. Its product roster includes best-selling Avonex, the most popular drug for the treatment of relapsing multiple sclerosis; Rituxan, a monoclonal antibody developed with Genentech that treats B-cell non-Hodgkin's lymphoma (NHL) and rheumatoid arthritis; multiple sclerosis and Crohn's disease drug Tysabri; and Fumaderm, a psoriasis drug marketed in Germany. Biogen Idec serves customers in more than 90 countries. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Biogen Idec Inc. Financials
| Company Type | Public - NASDAQ (GS): BIIB Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $4,097.5 |
| 2008 Employees | 4,700 |
Biogen Idec Inc. Executives
20 executives listed for Biogen Idec Inc.'s Cambridge, MA location.
| Title | Name & Bio | Contact |
| Chairman | Bruce Ross | Network |
| President, CEO, and Director | James Mullen | Network |
| COO | Robert Hamm | Network |
Competition
Competitive Landscape for Biogen Idec Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Biogen Idec Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
